Arena's Etrasimod Possesses Positive Attributes, But It Is Not Unique [Seeking Alpha]
CELGENE (CELG)
Last celgene earnings: 10/31 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.celgene.com
Company Research
Source: Seeking Alpha
Arena's Etrasimod Possesses Positive Attributes, But It Is Not Unique Summary Etrasimod has the potential to generate substantial revenues, but will likely face competition from similar S1P molecules. If a partner doesn't materialize, Arena has the means and willingness to advance etrasimod through FDA approval. Arena is likely to earn additional milestone payments and royalties from ralinepag, but timing remains uncertain. Arena Pharmaceuticals ARNA Management considers etrasimod unique and best-in-class only While it can be argued etrasimod is CELG NVS Sphingosine 1-phosphate From a fungus used in traditional Chinese medicine, a metabolite, myriocin, demonstrated an ability to modulate the immune system. S1P targets five known receptors labeled S1PR1-5, each affecting different tissues and organs. The first derived S1P molecule, fingolimod, marketed as Gilenyia received FDA and EU approval in 2010 and 2011 for relapsing forms of multiple sclerosis (MS). Fingolimod is non-selective f
Show less
Read more
Impact Snapshot
Event Time:
CELG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELG alerts
High impacting CELGENE news events
Weekly update
A roundup of the hottest topics